Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 45 years old
- People who are fluent in English
- People who are able to give their informed consent to participate
For people with schizophrenia, these additional criteria also apply:
- People who have a confirmed diagnosis of schizophrenia according to DSM-V diagnostic standards
- People who are either not taking antipsychotic medication, or who have been on a stable dose of antipsychotic medication for a consistent period
Who may not be able to join:
- People who have ferrous (magnetic) metal anywhere in their body
- People who are currently pregnant or breastfeeding
- People who have physical difficulties with hand or finger movement that would prevent them from completing a finger-tapping task
- People with an IQ below 85
- People who have a neurological condition, including epilepsy or a seizure disorder
- People who have significant hearing or vision loss
- People who have a long-term medical condition that affects their sleep
- People who have an unstable long-term medical condition, such as asthma, diabetes, cystic fibrosis, or heart disease
- People who have a diagnosed sleep disorder, with the exception of insomnia
- People who have a history of a head injury that caused an extended loss of consciousness or resulted in lasting neurological effects
For healthy adults (those without schizophrenia), these additional criteria also apply:
- People with a history of mental illness
- People currently taking psychiatric medications, or any medications known to affect sleep or cognition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 617-702-2368
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in sleep physiology; Changes in functional connectivity of the hippocampus and thalamus; Changes in hippocampal activation during motor sequence task (MST); Changes in hippocampal microstructural integrity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.